Drugs / GAD65
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00837759 | Feb 2009 → Mar 2011 | type 1 diabetes mellitus | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GAD65 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00837759 ↗ |
| Known as | Diamyd | “GAD65 (Diamyd)” NCT00837759 ↗ |